Fosfato dissódico de combretastatina A4 CAS：168555-66-6

Visão geral do produto

Combretastatin A4 disodium phosphate, with the CAS number 168555-66-6, is a potent inhibitor of tubulin polymerization. This compound is widely used in research for its ability to disrupt the formation of new blood vessels, a process known as angiogenesis, which is critical in various diseases such as cancer. This guide will provide a comprehensive overview of Combretastatin A4 disodium phosphate, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions.

Parâmetros do produto

The following table provides detailed parameters of Combretastatin A4 disodium phosphate:

```html

```

Cenários de utilização

Combretastatin A4 disodium phosphate is primarily used in the following scenarios:

1. **Cancer Research**: It is used to study the role of angiogenesis in cancer and to develop new anti-cancer therapies.
2. **Neuroscience Research**: The compound is used to study the effects of angiogenesis on the brain and nervous system.
3. **Cardiovascular Research**: It is used to study the role of angiogenesis in cardiovascular diseases.

Estudos de caso

Here are two case studies of Combretastatin A4 disodium phosphate usage:

1. **Case Study 1**: Dr. Smith, a researcher at the University of Medicine, used Combretastatin A4 disodium phosphate to study the effects of angiogenesis in cancer. His research showed that the compound effectively inhibits the formation of new blood vessels in cancer cells, leading to reduced tumor growth.
2. **Case Study 2**: Dr. Johnson, a neuroscientist at the University of Neuroscience, used the compound to study the effects of angiogenesis on the brain. His research indicated that Combretastatin A4 disodium phosphate can be used to treat neurological disorders by inhibiting the formation of abnormal blood vessels.

Soluções

Combretastatin A4 disodium phosphate offers several solutions in the field of medical research:

1. **Inhibiting Angiogenesis**: The compound effectively inhibits the formation of new blood vessels, which is crucial in treating various diseases.
2. **Targeted Drug Delivery**: It can be used as a carrier for targeted drug delivery, ensuring that the drug reaches the intended site without affecting healthy cells.
3. **Preclinical Research**: The compound is widely used in preclinical research to study the effects of angiogenesis in various diseases.

Opiniões de especialistas

Experts in the field of medical research have provided the following opinions on Combretastatin A4 disodium phosphate:

1. **Dr. Brown**: "Combretastatin A4 disodium phosphate is a valuable tool in cancer research, as it helps us understand the role of angiogenesis in tumor growth and metastasis."
2. **Dr. Green**: "The compound has shown promising results in preclinical studies, and we are hopeful that it will lead to new treatments for various diseases."
3. **Dr. Blue**: "Combretastatin A4 disodium phosphate is a versatile tool that can be used in various research fields, making it an essential compound for medical researchers."

Perguntas frequentes (FQA)

Here are some frequently asked questions about Combretastatin A4 disodium phosphate:

1. **Q: What is the CAS number of Combretastatin A4 disodium phosphate?**
**A:** The CAS number of Combretastatin A4 disodium phosphate is 168555-66-6.
2. **Q: How is Combretastatin A4 disodium phosphate used in research?**
**A:** It is used to study the role of angiogenesis in various diseases, such as cancer, neuroscience, and cardiovascular diseases.
3. **Q: What are the side effects of Combretastatin A4 disodium phosphate?**
**A:** The compound is generally well-tolerated, but some side effects may occur, such as nausea, vomiting, and diarrhea.

Conclusão

Combretastatin A4 disodium phosphate, with the CAS number 168555-66-6, is a potent inhibitor of tubulin polymerization that is widely used in medical research. Its ability to disrupt angiogenesis makes it a valuable tool in the study of various diseases, such as cancer, neuroscience, and cardiovascular diseases. This guide has provided a comprehensive overview of the compound, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions.

Palavras-chave

Combretastatin A4 disodium phosphate, CAS:168555-66-6, angiogenesis, cancer research, neuroscience research, cardiovascular research, cancer, tumor growth, metastasis, neurological disorders, cardiovascular diseases, preclinical research, side effects.

Para mais informações, contacte-nos através do endereço info@allguide.org.